NHS Greater Glasgow & Clyde Area Drug and Therapeutics Committee
Greater Glasgow and Clyde Medicines

Archive for 2018

Parkinson’s Disease in Acute Care

Posted: September 11, 2018.
Category - Medicines Update

The Medicines Update Extra Bulletin on Parkinson’s Disease (PD) in Acute Care has been updated. This consists of a main bulletin and 

Read More...

Guideline News Aug 2018

Posted: September 10, 2018.
Category - Medicines Update

New Adult NHSGGC Guidelines now available on StaffNet

Read More...

Primary Care Prescribing Decision Support Tools

Posted: September 07, 2018.
Category - Medicines Update

The NHSGGC Central Prescribing Team maintains several prescribing decision support tools for primary care such as;

Read More...

Clozapine and cytotoxic treatments

Posted: September 05, 2018.
Category - Medicines Update

Key messages The side effect profile of clozapine means it is subject to mandatory processes and monitoring which are intended to ensure patient safety Concurrent use of medications known to cause neutr...

Read More...

MUE 09: Parkinson's Disease in Acute Care

Posted: September 05, 2018.
Category - Medicines Update Extra

 MUE 09: Parkinson's Disease in Acute Care

** This bulletin supersedes MUE 01 **

  • It is CRUCIAL NOT TO STOP Parkinson’s Disease (PD) medications for any significant length of time as there is a risk of neuroleptic malignant-like syndrome which may be fatal.
  • Ensure early referral to the PD team to minimise risk of medication administration problems.
  • When a patient does not have an individual supply of PD medication, supply should be sought immediately via the local main holding areas of PD medications across NHSGGC. Refer to NHSGGC guidance “PD medication stock list, acute hospitals” on StaffNet for details or contact pharmacy.
  • For nil by mouth (NBM) patients, alternative routes need to be considered immediately. Seek advice from a PD specialist. Refer to NHSGGC “PD NBM guidance” on StaffNet, clinical pharmacist or Medicines Information for clinical advice if PD specialists are unavailable.
  • In PD patients undergoing surgery, consider the full NBM period including pre-operative preparation, the total duration of surgery and post-operative recovery. Ensure advance planning where possible to avoid missed doses.
  • Co-careldopa (Duodopa®) intestinal gel must be continued in patients established on treatment. Refer to NHSGGC guidance “Duodopa Monograph for maintaining co-careldopa (Duodopa®) intestinal infusion treatment in patients admitted to hospital” on StaffNet for details.
  • Apomorphine must be continued in patients established on treatment. Refer to NHSGGC guidance “Apomorphine Subcutaneous Infusion Treatment in Patients Admitted to Hospital” on StaffNet for details.

Read More...

Formulary Update (August 2018)

Posted: August 20, 2018.
Category - Formulary Update

This post summarises the latest NHS Greater Glasgow and Clyde decisions relating to new medicines considered by the Area Drug and Therapeutics Committee (ADTC) and uses a nationally developed format specifically aimed for patients and the public.

For full details of the medicines included in this post that are available for use, including any restrictions on prescribing, please see the relevant entry in the GGC Formulary.

Read More...

Crohn’s Disease: Use of Biologics in Adults

Posted: August 17, 2018.
Category - Medicines Update

The NHSGGC guideline previously entitled ‘Anti Tumour Necrosis Factor Alpha Medications In Adult Crohn’s Disease’ has been reviewed and updated. This is now available on the Clinical Guideline Repository on Staffnet

Read More...

Name change from enoxaparin Becat® to Arovi®

Posted: August 17, 2018.
Category - Medicines Update

Name change from enoxaparin Becat® to Arovi® and availability of 120mg and 150mg pre-filled syringes Key points: Enoxaparin Becat® is changing its name to Arovi®....

Read More...

Dipyridamole MR Supply Issues

Posted: August 17, 2018.
Category - Medicines Update

Dipyridamole MR 200mg is currently subject to supply disruptions, with no definitive date as to when or if the situation will be resolved. Persantin Retard® (dipyridamole 200mg MR) has been discontinued by the manufacture...

Read More...

ONS for adult patients with dysphagia

Posted: August 17, 2018.
Category - Medicines Update

The following information is for all clinicians who initiate prescriptions for ONS (oral nutritional supplements) for patients with dysphagia. In the interests of patient safety, care must be taken with this patient group to avoid aspir...

Read More...